Article · 2 Jun 2026
Conference abstract
Enhanced delivery of DNA-based vaccines and immunotherapeutics through next-generation electroporation devices
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is well established that injection of naked DNA vaccines alone is insufficient to generate clinically relevant immune responses due to inefficient cellular uptake. Over the past two decades, researchers have attempted to improve in vivo DNA delivery through multiple physical or chemical methods including in vivo electroporation (EP). Inovio Pharmaceuticals has recently demonstrated the potential of EP delivery technology for a therapeutic DNA vaccine in a Phase II clinical trial for HPVassociated cervical dysplasia. Therapeutic vaccination of CIN2/3 patients with VGX-3100, a highly optimized HPV-16/18 DNA vaccine administered by CELLECTRA® EP device resulted in robust cellular and humoral immune responses, significant viral clearance and importantly significant regression to CIN1 or no disease. Inovio is currently developing additional EP devices for DNA delivery to a variety of tissues such as muscle, skin and adipose tissue. Here we will discuss the impact of these devices on in vivo DNA uptake and how different EP strategies can be used to optimize delivery of DNA-based vaccines and immunotherapeutics for a variety of therapeutic indications.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Stephanie Ramos”
